From: drugtargetreview.com Researchers demonstrate that inhibiting the LMTK3 kinase is an effective anticancer strategy in murine models of breast cancer Researchers have solved the structure of Lemur Tyrosine Kinase 3 (LMTK3) and confirmed that it is an oncogenic target. The team are now working to develop LMTK3 inhibitors that could be orally administered for the treatment of various cancer types, …
‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence
From: purdue.edu Accurately diagnosing the spread of cancer often involves painful and invasive biopsy procedures. The use of a “liquid biopsy,” which involves a simple blood draw, has been shown in a five-year clinical trial to accurately detect and monitor certain kinds of breast cancer. The study involves circulating tumor DNA (ctDNA) and circulating tumor cells (CTC), genetic and cellular …